3rd Quarter - Report
SIDLEY AUSTIN LLP for INTERCEPT PHARMACEUTICALS, INC.
Firm
Income
$120,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FDA's regulation of rare disease drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL E BORDEN | Senior Counsel, House Financial Services Committee; Counsel, House Financial Services Committee; Legislative Assistant, Office of Rep. Jim Leach |
| PATRICIA LOUISE DELOATCHE | Health Policy Director, Sen. Orrin Hatch; Chief of Staff, Legislative Director, Legislative Assistant, Rep. Mike Bilirakis |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.